A detailed history of 1 North Wealth Services LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, 1 North Wealth Services LLC holds 25 shares of NTLA stock, worth $229. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25
Holding current value
$229
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$7.11 - $12.8 $177 - $320
25 New
25 $178,000

Others Institutions Holding NTLA

About Intellia Therapeutics, Inc.


  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $699M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track 1 North Wealth Services LLC Portfolio

Follow 1 North Wealth Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1 North Wealth Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on 1 North Wealth Services LLC with notifications on news.